Two Sigma Advisers’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
|
|||||
|
2025
Q4 | $345K | Sell |
|
|||||
|
2025
Q3 | $290K | Sell |
|
|||||
|
2025
Q2 | $565K | Sell |
|
|||||
|
2025
Q1 | $800K | Sell |
|
|||||
|
2024
Q4 | $1.61M | Sell |
|
|||||
|
2024
Q3 | $1.36M | Sell |
|
|||||
|
2024
Q2 | $3.49M | Buy |
|
|||||
|
2024
Q1 | $3.97M | Sell |
|
|||||
|
2023
Q4 | $3.35M | Sell |
|
|||||
|
2023
Q3 | $2.32M | Sell |
|
|||||
|
2023
Q2 | $1.96M | Buy |
|
|||||
|
2023
Q1 | $748K | Buy |
|
|||||
|
2022
Q4 | $466K | Buy |
|
|||||
|
2022
Q3 | $407K | Sell |
|
|||||
|
2022
Q2 | $545K | Buy |
|
|||||
|
2022
Q1 | $2.02M | Sell |
|
|||||
|
2021
Q4 | $6.71M | Buy |
|
|||||
|
2021
Q3 | $4.01M | Buy |
|